TCI GENE Inc. (TPEX:6879)
Taiwan · Delayed Price · Currency is TWD 36.70
+0.10 (0.27%)
Oct 8, 2026, 9:17 AM CST
TCI GENE Market Cap
TCI GENE has a market cap or net worth of 971.03 million as of October 9, 2026. It is the 34,114th most valuable company in the world and the 2,066th biggest in Taiwan. Its market cap has decreased by 9.61% in one year.
Market Cap
971.03M
Enterprise Value
139.75M
Revenue
251.39M
Global Rank
Country Rank
#2,066 Taiwan
PE Ratio
19.33
ChartMarket Cap Chart
Since January 25, 2022, TCI GENE's market cap has decreased from 2.14B to 971.03M, a decrease of -54.52%. That is a compound annual growth rate of -15.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 971.03M | 3.38% |
| Dec 31, 2025 | 939.28M | -34.50% |
| Dec 26, 2024 | 1.43B | -35.55% |
| Dec 29, 2023 | 2.23B | -28.42% |
| Dec 30, 2022 | 3.11B | 45.61% |
| Jan 25, 2022 | 2.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.20B |
| Bio Preventive Medicine | 1.16B |
| Enimmune | 1.16B |
| LabTurbo Biotech | 1.11B |
| BiOptic | 1.03B |
| GeneReach Biotechnology | 1.01B |
| Level Biotechnology | 1.01B |
| Meribank Biotech | 974.16M |